{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 462267014
| IUPAC_name = 2,2'-(2-hydroxyethylimino)bis [''N''-(1,1-dimethyl-2- phenylethyl)-''N''-methylacetamide]
| image = Oxetacaine.svg
| width = 280

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|oxetacaine}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = Oral, topical

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life = 1 hour
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 126-27-2
| ATC_prefix = C05
| ATC_suffix = AD06
| PubChem = 4621
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4460
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = IP8QT76V17
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01152
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 127592

<!--Chemical data-->
| C=28 | H=41 | N=3 | O=3 
| molecular_weight = 467.643 g/mol
| smiles = O=C(N(C(C)(C)Cc1ccccc1)C)CN(CCO)CC(=O)N(C(Cc2ccccc2)(C)C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C28H41N3O3/c1-27(2,19-23-13-9-7-10-14-23)29(5)25(33)21-31(17-18-32)22-26(34)30(6)28(3,4)20-24-15-11-8-12-16-24/h7-16,32H,17-22H2,1-6H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = FTLDJPRFCGDUFH-UHFFFAOYSA-N
}}
'''Oxetacaine''' ([[International Nonproprietary Name|INN]], also known as '''oxethazaine''') is a potent [[local anesthetic]]. It is administered orally (usually in combination with an [[antacid]]) for the relief of pain associated with [[peptic ulcer disease]] or [[esophagitis]]. It is also used topically in the management of [[hemorrhoid]] pain. Oral oxetacaine preparations are available in several countries, including [[India]], [[South Africa]], [[Japan]] and [[Brazil]], but not the United States.

Unlike most local anesthetics, oxetacaine does not break down under strongly [[acid]]ic conditions.<ref>{{cite journal |vauthors=Seifter J, Glassman JM, Hudyma GM |title=Oxethazaine and related congeners: a series of highly potent local anesthetics |journal=Proc Soc Exp Biol Med |volume=109 |issue= |pages=664â€“8 |year=1962 |pmid=13910333 |doi=10.3181/00379727-109-27300}}</ref> 
<!--What pH range?-->

==References==
{{Reflist}}

==External links==
*[http://www2.eisai.co.jp/di2/EPI/SR_T-G_EPI.pdf Strocain Prescribing information] from [[Eisai Co.]]
{{Local anesthetics}}
{{Vasoprotectives}}

[[Category:Local anesthetics]]
[[Category:Acetamides]]
[[Category:Alcohols]]


{{cardiovascular-drug-stub}}
{{nervous-system-drug-stub}}